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Abstract Protein adsorption onto calcium phosphate
(Ca–P) bioceramics utilised in hard tissue implant appli-
cations has been highlighted as one of the key events that
influences the subsequent biological response, in vivo. This
work reports on the use of surface-matrix assisted laser
desorption ionisation mass spectrometry (Surface-MALDI-
MS) as a technique for the direct detection of foetal bovine
serum (FBS) proteins adsorbed to hybrid calcium phos-
phate/titanium dioxide surfaces produced by a novel radio
frequency (RF) magnetron sputtering method incorporating
in situ annealing between 500C and 700C during depo-
sition. XRD and XPS analysis indicated that the coatings
produced at 700C were hybrid in nature, with the presence
of Ca–P and titanium dioxide clearly observed in the outer
surface layer. In addition to this, the Ca/P ratio was seen to
increase with increasing annealing temperature, with val-
ues of between 2.0 and 2.26 obtained for the 700C sam-
ples. After exposure to FBS solution, surface-MALDI-MS
indicated that there were significant differences in the
protein patterns as shown by unique peaks detected at
masses below 23.1 kDa for the different surfaces. These
adsorbates were assigned to a combination of growth fac-
tors and lipoproteins present in serum. From the data
obtained here it is evident that surface-MALDI-MS has
significant utility as a tool for studying the dynamic nature
of protein adsorption onto the surfaces of bioceramic
coatings, which most likely plays a significant role in
subsequent bioactivity of the materials.
1 Introduction
There is a great deal of interest in enhancing the surface
properties of calcium phosphate (Ca–P) bioceramic coat-
ings on hard tissue implant devices in order to increase
their performance in vivo. Of the many techniques avail-
able, radio frequency (RF) magnetron sputtering has been
identified as a particularly useful technique for the depo-
sition of such Ca–P thin films due to the ability of the
technique to provide greater control of the coating’s
properties and improved adhesion between the substrate
and the coating [1–14]. More recently, the addition of
titanium dioxide (TiO2) into Ca–P coatings in order to
create hybrid surfaces has been recognised as a key route
for enhancing their stability and providing the appropriate
biofunctionality [15–23].
Numerous reports have highlighted the importance of
protein adsorption to hydroxyapatite (HA) [24–30] and
TiO2 [31–34] surfaces in relation to cell growth (attach-
ment, spreading and differentiation) on hard tissue
implants. In particular, the role played by the individual
cell-adhesion serum proteins fibronectin and vitronectin in
initial attachment and spreading of cells [35]. Despite these
important findings the precise mechanisms of protein
adsorption and subsequent cell attachment and growth are
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still very poorly understood. One possible reason for this is
the complex nature of biological media like serum that
biomaterials are exposed to and the potential for involve-
ment of numerous other proteins co-adsorbing to surfaces,
potentially providing additional signals to attaching cells.
In human serum so far over 3,000 proteins have been
identified using classical proteomics approaches [36], and
it is a ‘‘mind boggling’’ thought that an estimated 50,000
molecular forms of the plasma proteins could actually exist
at any given time [37]. Foetal bovine serum (FBS), often
used as a cell culture medium, is even less ‘‘well charac-
terised’’. One recent report identified 91 proteins including
several growth factors in FBS [38], with many of the
species also found in human serum.
Studying protein adsorption is also an additional com-
plicating factor in biomaterials research. Despite numerous
methods being able to provide reliable quantitative data on
the adsorption of individual proteins adsorbed from single
solutions or from complex mixtures [39], new methods
need to be developed firstly to detect and secondly to
identify key components adsorbing from protein solutions
like serum. Matrix Assisted Laser Desorption Ionisation
Time-of-Flight Mass Spectrometry (MALDI-ToF-MS) is
an established method for detecting protein analytes in
solution at very low concentrations [40]. In conventional
MALDI-ToF-MS the protein is dissolved in a solution
together with photoactive molecules (e.g. trans-3,5-dime-
thoxy-4-hydroxy cinnamic acid/sinapinic acid). This mix-
ture is applied onto a sample stub and the solvent
evaporated to yield ‘‘photomatrix’’ crystals with encapsu-
lated protein molecules. Under ultra-high vacuum condi-
tions the crystals are irradiated with a pulsed UV laser
causing ablation. Proteins are ionised in the expanding
plume as a result of complex photochemical reactions [41]
and are extracted by an electrical potential before travelling
down the ToF flight tube to the detector. An adaptation of
the method is the so-called surface-MALDI technique
[42, 43]. After the protein adsorption experiment, and
thorough rinsing to remove loosely attached proteins,
droplets of the matrix solution are applied directly to the
protein coated surface. The solution consists of an organic
solvent (e.g. acetonitrile) and has a low pH, conditions that
are suitable for desorbing a substantial amount of the
adsorbed protein. After solvent evaporation matrix crystals
are formed in the conventional way with encapsulated
proteins, and the sample is glued to the MALDI sample
plate for analysis in the conventional way.
Our approach is to utilise surface-MALDI in an attempt
to detect and identify some of the proteins that adsorb to
the calcium phosphate/titanium dioxide hybrid coatings
surfaces from FBS solution. The experiments are aimed at
mimicking cell adhesion experiments to the hybrid coat-
ings, in which osteoblasts are suspended in 10% FBS
during cell culture [22]. In doing so we aim to detect
proteins that are common adsorbates to most modified
surfaces, and whose function in cellular responses may
well be unknown. The work provides a starting point for
taking a surface proteomics-like approach to understanding
biocompatibility of hard tissue implants by firstly identi-
fying key protein adsorbates.
2 Materials and methods
2.1 Sputtering procedure
For this study, titanium was sputter deposited onto abraded
Ti–6Al–4V substrates. Subsequently, Ca–P coatings were
deposited onto these polycrystalline titanium layers and
thermally annealed, in situ. All details of the deposition and
thermal processing conditions employed to create the
Ca–P/TiO2 hybrid surfaces are given below.
Titanium layers were sputter deposited onto abraded
Ti–6Al–4V substrates (Titanium International Ltd.)
(20 mm 9 20 mm 9 0.5 mm) from two titanium metal
targets ((99.995%) Kurt J. Lesker Ltd, USA) of 76 mm
diameter and 3.2 mm thickness. The targets were mounted
at 45 to the substrate surface. The break-in procedure prior
to deposition was conducted at a ramp rate of 15 W/min
(all with the source shutter closed). The base pressure was
below 7 9 10-5 Pa, with an argon gas flow rate (BOC,
99.995%) of between 15 and 20 standard cubic centimetres
per minute (sccm) at a chamber pressure of 2.0 Pascals (Pa)
and a throw distance of 100 mm. The deposition was
performed at 200 W for 1 h under the same atmospheric
conditions as were used for the target break-in procedure.
The approximate power density for the titanium targets was
8.7 W cm-2.
Hydroxyapatite (HA) targets, 76 mm in diameter and
5 mm thick were produced by dry pressing HA powder
(Merck KGaA, Darmstadt, Germany) at a load of 40 kN for
10 min with a loading rate of 10 kN/min. Radio Frequency
(RF) magnetron sputtering was performed using a cluster
of three high vacuum Torus 3 M sputtering sources in a
custom designed system (Kurt J. Lesker Ltd, USA) each
operating with a 13.56 MHz RF generator and an imped-
ance matching network (Huettinger, GmbH, Germany).
The sources were all mounted at 45 to the substrate sur-
face. For deposition from the HA targets onto the titanium
layers, the RF power in the sputtering system was ramped
up slowly to provide an initial break-in phase, thereby
minimising any thermal shock effects. The break-in prior to
deposition from the HA target was conducted at a ramp rate
of 5 Watts (W) per minute (all with the source shutter
closed). The base pressure was below 7 9 10-5 Pa, with an
argon gas flow rate (BOC, 99.995%) of between 15 and 18
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sccm at a chamber pressure of 2.0 Pascals (Pa) and a throw
distance of 100 mm. The fragility of the HA targets limited
their power absorption capacity and consequently deposi-
tion was performed at 150 W for 5 h under the same
atmospheric conditions as were used for the target break-in
procedure. The power density for these HA targets was
approximately 3.3 W cm-2.
In situ annealing was performed on the coatings during
sputter deposition. Heating was conducted using an array
of quartz lamps mounted immediately behind the substrates
in the sputtering system. The coatings were subjected to a
ramp rate of 5C/min to the processing temperature (with
the source shutters closed). in situ annealed was then per-
formed throughout the duration of the deposition cycle for
the Ca–P coating (5 h). After deposition of the Ca–P
coating the source shutters were closed and the coatings
were subjected to a ramp rate of 5C/min back down to a
temperature of less than 30C before they were removed
for characterisation. Coatings were produced at 500, 600
and 700C for this study.
2.2 Characterisation of the Ca–P/TiO2 coatings
X-Ray diffraction (XRD) of the samples were carried using
a Bruker D8 Discover Diffractometer fitted with a Gobel
Mirror. A Cu Ka X-ray radiation (k = 1.540 A˚) source was
employed with diffraction scans obtained at a tube voltage
of 40 kV and a tube current of 40 mA. Each diffraction
scan was recorded at 2h values from 20 to 50 with a step
size of 0.04 and a scan dwell time for each increment
of 30 s. For the grazing incidence angle XRD studies of
Ca–P/TiO2 coatings on the Ti–6Al–4V substrates the tube
angle was set to 0.75.
X-ray photoelectron spectroscopy (XPS) of the samples
were carried out using a Kratos Axis Ultra DLD spec-
trometer. Spectra were recorded by employing monochro-
mated AlKa X-rays (hm = 1,486.6 electron volts (eV))
operating at 15 kV and 15 mA (225 W). A hybrid lens
mode was employed during analysis (electrostatic and
magnetic), with an analysis area of approximately 300 lm
9 700 lm. For each sample, take off angles (TOAs) of 0,
45 and 75 (with respect to the sample surface) were
employed. Wide energy survey scans (WESS) were
obtained over the range 0–1,200 eV binding energy (BE) at
a pass energy of 160 eV. High resolution spectra were
recorded for C1s (280–303 eV), O1s (524–543 eV), Ca2p
(342–357 eV), Ti2p (448–469 eV) and P2p (126–141 eV)
at a pass energy of 20 eV. The Kratos charge neutraliser
system was used on all samples. Sample charging effects
on the measured BE positions were corrected by setting the
lowest BE component of the C1s spectral envelope to
285.0 eV, i.e. the value generally accepted for adventi-
tious carbon surface contamination [44]. Peak fitting of the
high-resolution spectral regions was performed by
subtraction of a linear background and application of a
mixed Gaussian–Lorentzian synthetic peak. Full width at
half-maximum (FWHM) values for each component were
in the range 1.4–1.6 eV and other parameters were applied
as part of the instrument-specific curve-fitting routine.
The surface topography of the samples were evaluated
using a Digital Instruments Dimension 3000 Scanning
Probe Microscope (SPM). The surface was scanned in
tapping mode over 5 lm 9 5 lm and 10 lm 9 10 lm areas
using a force modulated etched silicon probe (FESP) with a
nominal force constant of 0.28 N m-1. In tapping mode a
high frequency (75 kHz) z-oscillation is imposed upon the
probe during x–y raster scanning, which only allows
intermittent contact between the probe and the sample
surface. This eliminates shear forces because the probe is
not in constant contact with the sample. The images were
collected and subjected to minimal computational manip-
ulation, allowing only for a tilt removal.
The coating thickness of the titanium layers and the
Ca–P coatings were determined using a Dektak 8 stylus
profilometer (Veeco Instruments Inc, USA). Measurements
were taken across 10 step height positions on each sample
created by masking the Ti–6Al–4V substrates with alu-
minium foil prior to deposition in the sputtering system.
A 12.5 lm diameter diamond tipped stylus was employed
with scans lengths of 1,000 lm at a force of 15 mg.
2.3 Protein adsorption studies using
surface-MALDI-MS
The detection of proteins adsorbed to the calcium phos-
phate/titanium dioxide coatings exposed to 10% foetal
bovine serum (Cambrex, FBS) was undertaken using
MALDI-ToF-MS in surface mode (surface-MALDI). The
principles of this method have previously been described
[42, 43]. In brief, protein adsorption was performed by
exposing the surfaces to a 10% solution of heat treated FBS
for 1 h at 37C. The samples were then rinsed three times
in MilliQ water and left to air dry. Immediately after drying
the top surface of the sample was coated with enough
methanol to wet the entire surface (typically 100 ll). After
the methanol evaporated, 4–5 droplets of matrix solution
(0.5 or 1 ll) were applied and the samples left to air dry
immediately. The matrix is a saturated solution of sinapinic
acid (Fluka) in 1:1 acetonitrile (Fisher Scientific): 0.1%
trifluoroacetic acid (TFA, Sigma-Aldrich). The samples
were fixed to the MALDI sample plate using double-sided
sticky tape (Scotch) and inserted into the instrument.
MALDI-ToF-MS was performed using a Bruker Reflex
IV MALDI-ToF mass spectrometer (Bruker-Franzen
Analytik, Germany). The instrument uses a pulsed UV
laser (N2, 337 nm, 3 ns pulse-width) for protein ionization
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and delayed extraction combined with time-of-flight anal-
ysis for mass separation. Linear detection was employed
with a post-acceleration of 10 keV for improved sensitiv-
ity. For the surface-MALDI experiments the laser power
was adjusted to approximately 80% of its maximum for
maximum ion yields and, and the spectra presented are the
sum of 1,000 shots. External calibration was performed
using a bovine serum albumin standard with three point
calibration on the [M ? H]?, [2M ? H]? and [M ? 2H]2?
ions. All MALDI-MS experiments were performed in
duplicate.
3 Results and discussion
3.1 Stylus profilometry
The coating thickness of the titanium layers on the Ti–6Al–
4V substrates, as determined by stylus profilometry was
533 ± 43 nm. The coating thickness of the Ca–P coatings
was 320 ± 34 nm.
3.2 XRD
The XRD patterns for the Ti–6Al–4V substrate, the sputter
deposited titanium interlayer and the as-deposited Ca–P
coating on the titanium interlayer were reported previously
[23]. Upon in situ annealing of the Ca–P coating on the
titanium layer to 500C, the XRD data clearly indicates the
presence of HA, as shown in Fig. 1a. Peaks that are clearly
indicative of HA were seen throughout the pattern with 2h
values that correspond closely to those observed in the
ICDD file #09-0432 for HA. The four strongest peaks are
observed at 25.9, 31.7, 32.1 and 32.8 2h, and correspond
to 002, 210, 211 and 112 reflections, respectively. Fur-
thermore, the intensity of the 002 reflection at 25.9 2h
shows that this coating has a 002 preferred orientation,
typical of coatings deposited under the conditions
employed here [45, 46]. Peaks indicative of the underlying
titanium layer are also observed at 2h values similar to
those for titanium layer and correspond closely to those
observed for the ICDD file #44-1294 for titanium. The
XRD pattern for the Ca–P coating in situ annealed to
600C, as shown in Fig. 1b, also has peaks associated with
HA (ICDD file #09-0432 for HA), however, these peaks
show enhanced resolution when compared to the in situ
annealed 500C coatings. Peaks from the underlying tita-
nium are also observed at similar positions to those
observed for the coating at 500C. It is noticeable that no
rutile was detected in the sample in situ annealed to 600C
when compared to those produced by post deposition
annealing to the same temperature in earlier work [22, 23].
This difference is most likely a direct consequence that
post deposition annealing in previous studies was per-
formed in air, whereas the in situ annealing of the samples
here was performed under an argon gas pressure of 2 Pa
during sputter deposition. It is therefore suggested that the
formation of titanium dioxide and its subsequent diffusion
through the Ca–P outer layer is diminished during in situ
annealed due to the lack of available oxygen species
throughout the vacuum deposition process. Whenever these
coatings are in situ annealed to 700C, significant changes
are observed when against the in situ annealed surfaces at
500 and 600C. Peaks indicative of HA (ICDD file #09-
0432) and titanium (ICDD file #44-1294) are observed, as
shown in Fig. 1c. In addition to these, peaks corresponding
to rutile TiO2 are also evident at 27.4 and 35.9 2h, and
correspond closely to peaks observed in the ICDD file #21-
1276 for rutile TiO2. The titanium layer of the 700C in
situ annealed coatings has oxidised and diffused through
the HA layer more readily than the surfaces that were in
situ annealed at 500 and 600C.
3.3 XPS
The XPS data for the uppermost surface of the Ti–6Al–4V
substrate, the sputter deposited titanium interlayer (at a
Take Off Angle (TOA) of 0) and the as-deposited Ca–P
coating have been reported previously [23]. Furthermore,
the as-deposited coating was not analysed at different
TOAs due to the fact it would not be utilised in any of the
MALDI-MS experiments. From previous experience these
coatings showed a distinct lack of stability in physiological
fluid and were not stable enough to conduct such experi-
ments [10]. The XPS survey scan for the Ca–P coating on
the titanium layer in situ annealed to 500C (0 TOA) as
shown in Fig. 2 indicates similar peaks to those observed
for the as-deposited Ca–P coating. In addition to this low
levels of fluorine were detected for this in situ annealed
Fig. 1 XRD patterns for Ca–P coatings on titanium layers where
(a) ISA 500C, (b) ISA 600C and (c) ISA 700C samples (ISA—in
situ annealed)
74 J Mater Sci: Mater Med (2011) 22:71–84
123
500C Ca–P coating as shown in Table 1 and Fig. 2. It is
thought that the source of the fluorine signal observed in
the in situ annealed Ca–P coatings may be due to PTFE
materials used in the sputtering sources, however, as yet
this has not been confirmed. The results for the fitted high
resolution XPS data obtained for the C1s, O1s, Ca2p and
P2p regions of the Ca–P in situ annealed to 500C (0
TOA) are presented in Fig. 3 along with the tabulated data
for the same results in Tables 1, 2, 3, 4, 5, 6 (which also
includes the data for coatings analysed at TOAs of 45 and
75 for comparison). The C1s region, has been curve fitted
with three different components. The dominant peak
(285.0 eV) is attributed to hydrocarbon species, i.e. C–C
and/or C–H, present as a result of adventitious carbon
contamination [44]. The other peaks at 286.5 and 289.7 eV
are typical of C–O bonding and C=O bonding, respectively
[7, 47]. The corresponding O1s peak can be fitted into two
separate peaks. The most intense component at 531.2 eV
corresponds to an O–P bonded species and the second peak
at 532.5 eV can be attributed to oxygen bonded to carbon
and/or an OH- species [7, 48]. The Ca2p region for this in
situ annealed coating at 500C, exhibits a well-resolved
doublet with a Ca2p3/2 component at 347.5 eV and a
Ca2p1/2 component at 351.0 eV [7, 48]. The Ca2p1/2 and
Ca2p3/2 bands are separated by approximately 3.5 eV and
have the correct relative intensity ratio of 3:1. The fitted
P2p envelope indicates the presence of two components
with B.E. positions of 133.3 and 134.2 eV, which corre-
spond to the P2p3/2 and P2p1/2 states of phosphorus in a
Ca–P material, respectively [7, 49]. No peaks indicative of
titanium or any oxides of titanium were detected for this
particular surface. The Ca/P ratio of the Ca–P coating in
situ annealed to 500C (0 TOA) was 1.49, as reported in
Table 4, a value slightly lower than expected for stoichi-
ometric HA (1.67) [5]. Similar peak positions are also
observed for the Ca–P coating in situ annealed to 500C at
Fig. 2 XPS wide energy survey scan for the ISA 500C sample
(ISA—in situ annealed)
Table 1 XPS peak position
data for the Ca–P/TiO2 coatings
at 0C TOA (ISA—in situ
annealed)
Sample Peak position (binding energy) eV
C1s O1s Ca2p3/2 Ca2p1/2 Ti2p3/2 Ti2p1/2 P2p F1s
ISA 500 285 531.2 347.5 351 – – 133.3 685.3
286.5 532.5 134.2
289.7
ISA 600 285 531.2 347.6 351.1 458.8 463.5 133.3 684.5
286.4 532.2 134.3
289.4
ISA 700 285 531.2 347.5 351 458.6 463.8 133.2 685
286.4 532.1 134.1
288.9
Fig. 3 High resolution XPS spectra of a C1s, b O1s, c Ca2p and
d P2p for the ISA 500C sample (ISA—in situ annealed)
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45 and 75 take off angles, as shown in Tables 2 and 3,
respectively. No significant difference was observed in the
Ca/P ratio for the spectra collected at either of these take
off angles, as shown in Tables 5 and 6.
However, after in situ annealing of the Ca–P coatings
deposited onto the titanium layer to 600C (0 TOA),
significant differences were observed and a weak Ti2p
peak was detected. The distribution of peaks in the Ti2p
envelope for this coating indicates the presence of TiO2
with peaks at 458.8 eV (Ti2p3/2) and at 463.5 eV (Ti2p1/2)
[50–52] as given in Table 1. No significant change was
observed in the Ca/P ratio of this coating (1.57) when
compared to that observed for the coating in situ annealed
to 500C (0 TOA) at 1.49. Furthermore, no significant
differences in the BE contributions of the fitted XPS
spectral data for the Ca–P coatings in situ annealed to
600C (0 TOA) were evident. Similar results were
observed for the fitted spectra for the in situ annealed
coating at 600C (45 TOA), with a Ca/P ratio of 1.53.
However, the XPS data for the in situ annealed 600C at a
TOA of 75 indicates a significant increase in the Ca/P
Table 2 XPS peak position
data for the Ca–P/TiO2 coatings
at 45C TOA (ISA—in situ
annealed)
Sample Peak position (binding energy) eV
C1s O1s Ca2p3/2 Ca2p1/2 Ti2p3/2 Ti2p1/2 P2p F1s
ISA 500 285 531.2 347.4 350.9 – – 133.2 685.3
286.4 532.2 134.1
288.6
ISA 600 285 531.2 347.4 351 458.8 463.8 133.2 684.5
286.4 532.5 134.1
289.4
ISA 700 285 531.3 347.5 351 458.7 463.8 133.1 685.2
286.4 532.5 134.1
289
Table 3 XPS peak position
data for the Ca–P/TiO2 coatings
at 75C TOA (ISA—in situ
annealed)
Sample Peak position (binding energy) eV
C1s O1s Ca2p3/2 Ca2p1/2 Ti2p3/2 Ti2p1/2 P2p F1s
ISA 500 285 531.3 347.4 350.9 – – 133.1 684.4
286.5 532.2 134.1
288.5
ISA 600 285 531.2 347.4 350.9 – – 133.2 684.4
286.5 532.3 134.3
288.9
ISA 700 285 531.2 347.6 351.1 458.7 464.1 133.1 685.1
286.4 532.2 134.1
289.2
Table 4 XPS quantitative data for the Ca–P/TiO2 coatings at 0C
TOA (ISA—in situ annealed)
Sample % Atomic concentration
C1s O1s Ca2p P2p Ti2p F1s Ca/P
ISA 500 28.6 44.5 14.5 9.7 – 2.8 1.49
ISA 600 29.4 41.5 13.4 8.5 0.4 6.8 1.57
ISA 700 30.1 41.1 13.6 6.8 0.7 7.7 2.00
Table 5 XPS quantitative data for the Ca–P/TiO2 coatings at 45C
TOA (ISA—in situ annealed)
Sample % Atomic concentration
C1s O1s Ca2p P2p Ti2p F1s Ca/P
ISA 500 35.6 38.8 13.7 9.6 – 2.1 1.43
ISA 600 34.3 39.2 13.3 8.7 0.5 4.1 1.53
ISA 700 33.0 38.6 14.3 7.1 0.7 6.4 2.01
Table 6 XPS quantitative data for the Ca–P/TiO2 coatings at 75C
TOA (ISA—in situ annealed)
Sample % Atomic concentration
C1s O1s Ca2p P2p Ti2p F1s Ca/P
ISA 500 46.9 31.5 11.8 7.8 – 1.9 1.51
ISA 600 33.2 40.2 11.1 6.1 – 9.7 1.83
ISA 700 36.5 35.9 14.6 6.4 0.6 6.0 2.26
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ratio to 1.83. In addition, no peaks indicative of titanium
(or oxides of titanium) were observed for these coatings in
situ annealed to 600C at a TOA of 75.
In comparison, in situ annealing of the Ca–P coatings to
700C (0 TOA) produced surfaces that had a very high
Ca/P ratio (2.00) as given by the XPS data in Table 4. The
fitted Ti2p envelope indicated the presence of peaks
indicative of TiO2 at 458.6 eV (Ti2p3/2) and at 463.8 eV
(Ti2p1/2) [50–52]. Similarly, the Ca/P ratio of the coating in
situ annealed to 700C (45 TOA) was high at 2.01 as
given in Table 5. The fitted XPS spectral data did not show
any significant differences when compared to those
observed after in situ annealing to 700C (0 TOA), as
shown in Table 2. The Ca/P ratio did however increase
significantly after analysing the 700C in situ annealed
coating at a TOA of 75 to 2.26, as shown in Table 6. This
result is not un-expected for coatings produced using this
method and indicates a calcium rich surface. In addition to
this, peaks indicative of TiO2 are clearly observed in the
Ti2p spectral envelope for the 700C in situ annealed
coating (75 TOA).
The stoichiometry obtained from the XPS analysis of the
coatings annealed to 500 and 600C at TOAs of 0 and 45
are close to that of tri-calcium phosphate (TCP) (Ca/P—
1.5). Despite this the XRD data clearly shows the presence
of HA material only. This may suggest that the levels of
TCP are below the detection limits of the XRD technique
or that the coatings in situ annealed at these temperatures
have a phosphorus rich surface [23]. This is also the case
for the 500C surface analysed at a TOA of 75. In contrast
to these results, the Ca/P ratios obtained for the surfaces in
situ annealed to 700C (at all TOAs utilised in this study)
indicated Ca/P ratios of 2.0–2.26 which highlights the
calcium rich nature of the uppermost surfaces created here.
This is also true for the 600C in situ annealed sample at a
TOA of 75. These XPS results clearly show an increase in
the Ca/P ratio with increasing in situ annealing tempera-
ture, as has been observed in previous studies [23]. In
addition to this, the data presented here also confirm that
this process is predominantly a surface phenomenon given
the significant increases in the Ca/P ratio observed at the
75 TOAs for the 600 and 700C samples. This supports
previous assumptions that the increase in the Ca/P ratio as a
result of increasing annealing temperature (in situ) is a
consequence of the evaporation of volatile phosphorus
species from the surfaces of such sputter deposited samples
[23]. Previous work, which utilised post-deposition
annealed of similar calcium phosphate samples in air
showed an increase in the Ca/P ratio with increasing
annealing temperature (to a maximum of 500C), which is
consistent with the results observed here [7, 10, 13].
However, in previous studies performed using post depo-
sition annealing in air to 600 and 700C, the Ca/P ratio is
seen to fall significantly and in these cases, the incorpo-
ration of TiO2 has been attributed to the stability of the
coatings and the impediment of the evaporation of any
phosphorus species. In the case of the in situ annealed
samples, thermal processing was carried out over a period
of 5 h (when compared to the 2 h for the post deposition
annealed samples in previous studies) [23]. As such, the
increase in the Ca/P ratio observed for the in situ annealing
samples (especially in the outermost surfaces regions, as
given by the change in the TOA of the XPS analysis) could
be explained by this increased annealing time, which has
resulted in the evaporation of any volatile phosphorus
products from the surface leaving a more Ca rich layer.
From these XPS results it is apparent that only the 700C in
situ annealed sample shows a hybrid HA/TiO2 outermost
surface layer when compared to the 500 and 600C in situ
annealed coatings, and concurs with the data obtained from
the XRD analyses. The presence of CaTiO3 in the outmost
surface of the 700C in situ annealed samples can be ruled
out due to the fact that peak positions observed for the Ti2p
envelope given in Tables 1, 2, 3 (for TOAs of 0, 45 and
75, respectively) correspond to that for TiO2 at approxi-
mately 458.8 eV [53]. Typically, the titanium bonding
states for CaTiO3 are observed around 459.2 eV [53].
3.4 AFM
The AFM images of the Ti–6Al–4V substrate in Fig. 4a
(5 lm 9 5 lm) show a series of surface features including
random abrasion scratches, small hillocks, pits and fissures.
In the case of the abrasion scratches these range in width
from 0.3 to 1.0 lm and in depth from 0.1 to 0.3 lm. For the
Ti–6Al–4V substrate coated with a titanium layer, titanium
crystallites of up to 200 nm in diameter seem to have formed
preferentially around the more prominent surface features
on the substrate as shown in Fig. 4b (5 lm 9 5 lm). The
corresponding AFM images for the as-deposited Ca–P
coating as illustrated in Fig. 4c (5 lm 9 5 lm) show a
relative tendency for the coatings to mimic the substrate
topography and to conform to striations and defects pro-
duced by the abrasion of the substrate. However, there is
evidence from the AFM to suggest that there has been
significant in-filling of the larger pits and fissures on the
substrate surface, which is typical of previous studies uti-
lising similar RF magnetron sputter deposited calcium
phosphate coatings [7, 10, 23].
The AFM image for the 500C in situ annealed surface,
as shown in Fig. 5a (10 lm 9 10 lm), appears to indicate
that the coatings transforms into one that exhibits a series
of sharp columnar features right across the coating surface
and range in size from 0.1 to 0.5 lm. These values
approximate closely to those observed before for sputter
deposited Ca–P coatings [7, 10, 23]. The coating in situ
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annealed to 600C has transformed into one that exhibits
large spherical features that are between 0.5 and 1.5 lm, as
shown in Fig. 5b. The sample in situ annealed to 700C
shows further significant change in the surface morphol-
ogy, with the larger columnar structures becoming more
prominent. Small nanocrystallite features of up to 100 nm
are also observed across the entire surface of the 700C in
situ annealed samples and are organised into small chains
as shown in Fig. 5c. Similar data were obtained for such
coatings in previous studies [23]. These AFM results, as
with the XPS and XRD data, clearly indicate that only the
700C in situ annealed coatings shows a hybrid HA/TiO2
outermost surface layer when compared to the 500C and
600C in situ annealed surfaces.
3.5 Protein adsorption
3.5.1 Surface-MALDI
Surface-MALDI has proven to be a very useful technique
at detecting proteins adsorbed to surfaces [42, 43],
Fig. 4 AFM images (5 lm 9 5 lm) of a abraded Ti–6Al–4V
substrate, b titanium coated Ti–6Al–4V substrate and c as-received
Ca–P coating
Fig. 5 AFM images (10 lm 9 10 lm) of a ISA 500C, b ISA 600C
and c ISA 700C samples (ISA—in situ annealed)
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particularly from complex protein solutions, such as serum.
Indeed, MALDI appears to be a suitable technique that has
the promise to detect multiply adsorbed proteins on planar
surfaces exposed to serum. In particular, it has the sensi-
tivity to detect proteins with concentrations in the low
ng/cm2 range, over areas of a few mm2. The experiments
were chosen to mimic the cell culture environment in
which the cells are suspended in 10% FBS solution. The
question asked was, are there serum proteins that adsorb to
the different coatings that could influence the cell behav-
iour? Our methodology is initially based on determining
whether surface-MALDI can detect proteins adsorbed to
the different coatings produced here to be used for bone
regeneration, and potentially identifying the species present
based on existing knowledge of the composition of serum.
The knowledge generated will be utilised in future work
where a more comprehensive programme of cellular
responses to the individual components detected from the
serum experiments will be undertaken.
Figure 6 shows a surface-MALDI spectrum recorded
from the Ti–6Al–4V substrate after 1 h exposure to 10%
FBS. Figure 6a shows the spectrum ranging from 5 to
100 kDa, and Fig. 6b shows the expanded plot from 5 to
25 kDa. Clearly, a large number of peaks are present in the
spectra indicating that many different serum proteins
adsorb to the Ti–6Al–4V surface. The major peaks in the
spectrum, along with potential assignments are summarised
in Table 7. A combination of literature [38, 54] reports and
known bovine and human proteins in the iProClass data-
base [55] were used to interpret the spectra. We tentatively
base the assignments on knowledge of proteins detected in
human serum with medium to high concentrations, since
such knowledge is unavailable for bovine serum. Serum
albumin is clearly the major protein detected with two
peaks at 68.3 and 34.3 kDa corresponding to the
[M ? H]?, [2M ? H]? ions, respectively. The highest
molecular weight protein detected is assigned to adsorbed
transferrin, with a molecular weight of 79.4 kDa. There are
a number of high molecular weight proteins known to be in
serum at quite concentrations that are either not detected or
not considered due to the limitations in detection based on
instrument limitations including fibronectin (MW 250
kDa), alpha-2-macroglobulin (MW 160 kDa), ceruplasmin
(MW 120 kDa), plasminogen (MW 88 kDa), integrin b-1
(MW 88 kDa), and cone cGP-specific 30,50-cyclic phos-
phodiesterase a-subunit. It cannot be ruled out that some of
the low molecular weight species detected are fragments of
these proteins. In addition, we are also assuming that FBS
has very few immunoglobulins present and that the prep-
aration and heat inactivation of FBS eliminates plasma
proteins involved in coagulation and the complement pro-
teins. However, it should be noted that antithrombin III has
been detected in FBS using LC-MS [4].
The largest and most broad peak occurs in the molecular
weight range 38.4–51.7 kDa. Unfortunately due to the low
mass resolution of the MALDI instrument operating in
linear mode the peak is unresolvable. The broadness of
the peak most likely corresponds to spectral overlap
from adsorption of a large number of the most abundant
serum proteins in this molecular weight range including
haptoglobulin (44,859 Da), a-1-antitrypsin (46,104 Da),
a-1-antichymotrypsin (46,954 Da), beta-2-glycoprotein
(38,252 Da), alpha-2-hs-glycoprotein (39,325 Da), and a-1-
1-microglobulin and inter-a-trypsin inhibitor light chain
(39,232 Da). Similarly a small but broad peak is detected in
the mass range 52.7–57.1 kDa. A number of known proteins
possibly adsorb in this mass range that are known to be quite
concentrated in human serum including vitamin-d-binding
protein (53,342 Da), vitronectin (53,575 Da), alpha-1B-
glycoprotein (54,273 Da), hemopexin (51,676 Da), anti-
thrombin III (52,347 Da), and a-2 antiplasmin (54,711 Da).
Furthermore, it should be noted that the low intensity of
the peak suggests that the surface concentration of these
components is quite low.
The large peak at *23.7 kDa does not have any obvi-
ous candidates from the literature. However, it has been
shown that growth factors can be present in FBS [4],
Fig. 6 Surface-MALDI data recorded from the Ti–6Al–4V substrate
after 1 h exposure to 10% FBS where a 5–100 kDa spectrum range,
and b 5–25 kDa spectrum range
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Table 7 Summary of the surface-MALDI data generated from the Ti–6Al–4V substrate exposed to 10% FBS and possible assignments based on
information obtained from the iProClass database for bovine proteins (http://pir.georgetown.edu/)
Peak no. Detected
MW (kDa)
Possible assignment Known
MW (Da)
Concentrationa
in serum (lg/ml)
ID
1 79.4 Transferrin 77753 2660 A60166
2a, 2b 68.3, 34.3 Albumin 69293 45000 ABBOS
3 52.7–57.1 Vitamin-d-binding protein 53342 400 VTDB
3 52.7–57.1 Vitronectin 53575 340 Q3ZBS7
3 52.7–57.1 a-1B-Glycoprotein 54273 (H) 225 P04217
3 52.7–57.1 Hemopexin 51676 200 Q3SZV7
3 52.7–57.1 Antithrombin III 52347 145b ANT3
3 52.7–57.1 a-2 Antiplasmin 54711 60b A2AP
4 38.4–51.0 Haptoglobulin 44859 1365 Q2TBU0
4 38.4–51.0 a-1-Antitrypsin 46104 1235 A1AT
4 38.4–51.0 a-1-Antichymotrypsin 46954 450 S66289
4 38.4–51.0 b-2-Glycoprotein 38252 220 APOH
4 38.4–51.0 a-2-hs-Glycoprotein 39325 (H) 625 A2HS
4 38.4–51.0 a-1-1-Microglobulin and inter-a-trypsin
inhibitor light chain
39232 Unknown AMBP
5 23.7 Platelet-derived growth factor beta isoform 1 23723 Unknown Q58D48
5 23.7 Interleukin 6 (IL-6) 23759 Unknown P26892
6 23.0 a-1-Acid-glycoprotein 23182 870 A1AG
7 20.3 Plasma retinol binding protein 21069 55 P18902
7 20.3 Interleukin 10 (IL-10) 20411 Unknown P43480
7 20.3 Fibroblast growth factor 12 isoform 2 20424 Unknown Q5E9M0
7 20.3 Fibronectin variable factor 20378 Unknown Q9MZ31
7 20.3 Transforming growth factor beta regulator 1 20429 Unknown Q0V8K6
8 19.7 Insulin-like growth factor II (IGF-II) 19682 Unknown P07456
9 16.3 LPS-binding protein 16980 18 Q2KVH3
10 15.3 Apolipoprotein B100 15653 (H) 1330 Q13789
10 15.3 Prealbumin 15727 345 O46375
10 15.3 Hemoglobin beta fetal chain 15859 Unknown HBBF
11 15.0 Hemoglobin a-chain 15184 Unknown HBA
12 14.1 Serum amyloid A 14516 10 P35541
13 13.1 b-2-Microglobulin 13667 16 P01888
14 11.9 Unknown
15 10.5 Apolipoprotein A-II 11202 460 APA2
16 10.2 Apolipoprotein C-III 10692 124 P19035
17 9.9 Alpha 1-antichymotrypsin (Fragment) 9794 Unknown Q28922
18 9.5 Platelet factor 4 9523 Unknown P02777
18 9.5 Apolipoprotein C-1 9332 (H) 7 P02654
19 8.7 Apolipoprotein C-II 8606 33 P19034
20 8.2 Unknown
21 8.0 Unknown
22 7.7 Unknown
23 7.1 Unknown
24 6.0 Unknown
a Concentration in human serum [3], unknown for FBS. (H) Human assignment. b Detected in FBS in high abundance [4]
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however, there were major differences from supplier to
supplier making it difficult to assign any peaks to these
protein species. One possible candidate is platelet-derived
growth factor beta isoform 1 (23,723 Da) that been cited in
the iProClass database. An additional candidate could be
Interleukin 6 (IL-6) (23,759 Da), which has been detected
adsorbed to heparin coated extracorporeal circuits exposed
to plasma [56]. Furthermore, there are additional peaks in
the spectrum that are potentially growth factors at mass
values 20.3 and 19.7 kDa for fibroblast growth factor 12
isoform 2 (20,424 Da) or transforming growth factor beta
regulator 1 (20,429 Da) and insulin-like growth factor II
(IGF-II) (19,682 Da). Their concentration in FBS is
unknown. Other candidates for the peak at 20.3 kDa
include Interleukin 10 (IL-10) (20,411 Da) and fibronectin
variable factor (20,378 Da).
There are a number of proteins detected that are tenta-
tively assigned to apolipoproteins. These include apolipo-
protein B100 (15.3 kDa), apolipoprotein A-II (10.5 kDa),
apolipoprotein C-III (10.2 kDa), apolipoprotein C-1
(9.5 kDa), and apolipoprotein C-II (8.7 kDa). However, the
peak at 15.3 kDa has several other possible overlapping
candidates including prealbumin (15,727 Da), and hemo-
globin beta fetal chain (15,859 Da). Interestingly, no apo-
lipoprotein A1 (Apo-A1, MW 30,276 Da) or
apolipoprotein E (Apo E, MW 35,980 Da) is detected.
Both these proteins are quite abundant in serum and have
been associated with opsonization of particle drug carriers
and wear particles in orthopaedics. Apo E has been
implicated in adsorbing to the surface of phosphatidyl
serine containing liposomes [57], and Apo A1 has been
shown to be a key protein adsorbing from serum onto wear
particles in hip-joint replacement, along with albumin and
a-1-antitrypsin [58]. Apo A1 has also been shown to adsorb
to the surface of copolymer nanoparticles from plasma
[59].
Several additional proteins were detected at 15.0, 14.1,
13.1. 9.9 and 9.5 kDa and these are tentatively assigned to
low abundant proteins hemoglobin a-chain (15,184 Da),
serum amyloid A (14,516 Da), beta-2-microglobulin
(13,667 Da), alpha 1-antichymotrypsin (Fragment)
(9,794 Da), platelet factor 4 (9,523 Da). Finally, a number
of other peaks are present in the spectrum and it is not
possible to provide any possible assignments to them (11.9,
8.2, 8.0, 7.7, 7.1, and 6.0 kDa) based on current knowledge
despite there being a large number of possibilities in the
protein databases. Handling of serum and its preparation
from plasma can change its composition by producing
proteolytic fragments of larger protein [60, 61].
The coatings produced here were also assessed by sur-
face-MALDI after 1 h exposure to 10% FBS. Figure 7
shows the spectrum of the in situ annealed 700C surface
and clearly shows a number of similarities to the control
surface, however, a number of peaks are not present in the
spectrum. Table 8 is a summary of the peaks detected for
all the hydrid coatings generated from the surface-MALDI
data. The only additional protein detected on any of the
surfaces is a low intensity peak at 28.5 kDa, which is
adsorbed to the in situ annealed 500C surface. This may
be apolipoprotein A1, although the mass is lower than
expected for bovine Apo A1 (MW 30,276 Da). The major
peaks detected on the control substrate appear on all
the hybrid surfaces tested, namely, at 68.3, 34.3 kDa
(albumin), 38.4–51.0 kDa (haptoglobulin, a-1-antitrypsin,
a-1-antichymotrypsin, beta-2-glycoprotein, alpha-2-hs-gly-
coprotein, a-1-1-microglobulin and inter-a-trypsin inhibitor
light chain), 23.7 kDa (platelet-derived growth factor beta
isoform 1 and Interleukin 6 (IL-6)), 20.3 kDa (fibroblast
growth factor 12 isoform 2 or transforming growth factor
beta regulator 1), 15.3 kDa (apolipoprotein B100, prealbu-
min, or hemoglobin beta fetal chain), 10.5 kDa (apolipo-
protein A-II), 10.2 kDa (apolipoprotein C-III), 9.9 kDa
(Alpha 1-antichymotrypsin (Fragment)), and 8.7 kDa
(apolipoprotein C-II). There are also traces of transferrin
(79.4), vitamin-d-binding protein, or vitronectin, or alpha-
1B-glycoprotein, or hemopexin, or antithrombin III, and/or
a-2 antiplasmin in the mass range 38.4–51.0 kDa. In
addition, there are clear variations in the relative intensities
Fig. 7 Surface-MALDI spectrum for the ISA 700C sample (ISA—
in situ annealed)
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of the peaks between samples, which clearly indicate
differences in the surface concentrations of each of the
species.
What is clear from the surface-MALDI-MS results is
that the coatings produced here inhibit the adsorption of a
range of specific proteins with molecular weights (MWs) of
less than 23.1 kDa more readily than those at higher MWs
([23.1 kDa), as shown in Table 8. In addition to this, the
adsorption of proteins associated with peaks at MWs of
between 52.7 and 57.1 kDa are also inhibited in the in situ
annealed 700C samples. Furthermore, both the in situ
annealed 600C and in situ annealed 700C samples inhibit
the adsorption of a greater range of proteins than the in situ
annealed 500C samples or the Ti–6Al–4V substrate as
shown in Tables 7 and 8. These particular samples show a
higher Ca/P ratio in the uppermost surface region from the
XPS data (75 TOA) when compared to the in situ
annealed 500C samples. Generally, an increase in the
Ca/P ratio increases the adsorption rate of proteins onto the
surface of Ca–P materials, however, this phenomenon has
been shown to differ greatly depending on the protein in
question [62]. These adsorbates were assigned to a com-
bination of growth factors and lipoproteins present in
serum.
Direct identification of the proteins/peptides detected on
the surfaces, apart from perhaps some of the most con-
centrated proteins in serum, is not possible on account of
the complexity of serum. However, actual detection by
surface-MALDI indicates that they are present in signifi-
cant concentrations at the interface between the implant
surface and the cells. Additionally, the data generated
highlights the complexity of protein adsorption phenomena
when surfaces are exposed to biological fluids such as
bovine serum. There are significant differences between all
the surfaces in terms of peaks detected, which may trans-
late into differences in cellular responses. In order to
determine more precisely the compositions of the protein
adlayers and the function of the individual proteins on the
hybrid coatings classical proteomics approaches will most
likely be needed in combination with experiments involv-
ing sera selectively depleted of suspected proteins or sera
that have been fractionated, e.g. by dialysis or gel perme-
ation chromatography. Our initial studies most certainly
highlight the need for more advanced methods of identi-
fying protein adsorbates on surfaces where proteins are
allowed to freely adsorb, and are likely to influence initial
cell attachment and growth on biomaterials. Such phe-
nomena are obviously very important but too often over-
looked in the biomaterials community.
4 Conclusions
A range of different Ca–P and Ca–P/TiO2 surfaces were
produced in this study utilising RF magnetron sputtering.
The surfaces, which were produced via an in situ annealing
approach during sputter deposition were characterised
using surface specific analytical techniques. These analyses
highlighted the fact that a hybrid Ca–P/TiO2 surface was
only produced after in situ annealing to 700C, whereas the
coatings produced at 500 and 600C displayed the char-
acteristics of a Ca–P surface, most notably at the higher
TOA (75). This study clearly indicates that surface-
MALDI-MS has significant utility as a tool for studying the
dynamic nature of protein adsorption onto the surfaces of
bioceramic coatings. In addition, differences in the coating
properties were seen to have a significant influence on the
nature of the protein adsorption. However, due to the
complexity of the systems studied here it is recognised that
additional studies will have to be undertaken in order to
elucidate the exact nature of the protein adsorption
observed here. The in vitro cellular responses to these
materials in the presence of serum have been started and
will be presented in a future manuscript.
Table 8 Summary of the protein peaks detected on the various Ca–P
surfaces (ISA—in situ annealed)
Peak No. Detected
MW (kDa)
Surface
ISA 500 ISA 600 ISA 700
1 79.4 Trace Trace Trace
2a, 2b 68.3, 34.3 Yes Yes Yes
3 52.7–57.1 Trace Trace No
4 38.4–51.0 Yes Yes Yes
5 23.7 Yes Yes Yes
6 23.0 Yes No No
7 20.3 Yes Trace Yes
8 19.7 No No Trace
9 16.3 Yes Trace No
10 15.3 Yes Yes Yes
11 15.0 Trace No No
12 14.1 Yes No Yes
13 13.1 Trace No No
14 11.9 No Yes Yes
15 10.5 Yes Yes Yes
16 10.2 Yes Yes Yes
17 9.9 Yes Yes Yes
18 9.5 Trace No Yes
19 8.7 Yes Yes Yes
20 8.2 Trace Trace Trace
21 8.0 Trace Trace Trace
22 7.7 No No No
23 7.1 No No No
24 6.0 Trace No No
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